DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Tech
Updated 1m ago
2352 logo

Qisda CorporationTWSE:2352 Stock Report

Market Cap NT$45.4b
Updated 1m ago
Share Price
n/a
1Y-25.5%
7D-1.0%
1D-1.4%
Portfolio Value
​
View

Qisda Corporation

TWSE:2352 Stock Report

Market Cap: NT$45.4b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Qisda (2352) Stock Overview

Manufactures, sells, and services monitors, opto-mechatronics products, and optoelectronics film in Taiwan, the Americas, Mainland China, Japan, and internationally. More details

2352 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends2/6

Rewards

Earnings are forecast to grow 40.73% per year

Risk Analysis

Interest payments are not well covered by earnings

Dividend of 3.53% is not well covered by earnings or free cash flows

Large one-off items impacting financial results

Profit margins (0.6%) are lower than last year (1%)


2352 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
13.0% undervalued intrinsic discount
AnalystConsensusTarget
•3mo ago

2352: Investments In AIoT And Medical Services Will Boost Future Profitability

68
0
0
AN
AnalystHighTarget
14.6% undervalued intrinsic discount
AnalystHighTarget
•2mo ago

Medical And Smart Business Solutions Will Redefine This Electronics Group’s Future Potential

9
0
0
AN
AnalystLowTarget
11.4% undervalued intrinsic discount
AnalystLowTarget
•7mo ago

AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround

2
0
0

Top Analyst Narratives

AN
AnalystConsensusTarget
13.0% undervalued intrinsic discount
AnalystConsensusTarget
•3mo ago

2352: Investments In AIoT And Medical Services Will Boost Future Profitability

68
0
0
AN
AnalystHighTarget
14.6% undervalued intrinsic discount
AnalystHighTarget
•2mo ago

Medical And Smart Business Solutions Will Redefine This Electronics Group’s Future Potential

9
0
0
AN
AnalystLowTarget
11.4% undervalued intrinsic discount
AnalystLowTarget
•7mo ago

AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround

2
0
0
View all narratives

Qisda Corporation Competitors

Kinpo Electronics

Symbol: TWSE:2312
Market cap: NT$46.5b

ASRock Rack Incorporation

Symbol: TWSE:7711
Market cap: NT$34.3b

META Green Cooling Technology

Symbol: TPEX:7892
Market cap: NT$39.0b

Ennoconn

Symbol: TWSE:6414
Market cap: NT$55.9b

Price History & Performance

Summary of share price highs, lows and changes for Qisda
Historical stock prices
Current Share PriceNT$28.35
52 Week HighNT$38.72
52 Week LowNT$22.55
Beta0.61
1 Month Change-3.90%
3 Month Change-7.95%
1 Year Change-25.49%
3 Year Change-48.85%
5 Year Change-19.14%
Change since IPO-20.28%

Recent News & Updates

Recent updates

User avatar
Narrative Update • Jun 26

2352: Higher Discount Rate And Compressed P/E Will Shape A Fair Outlook

Analysts have revised their price target for Qisda to NT$33.20 from NT$41.46, citing updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiples. What’s in the News for Qisda No recent Qisda specific news items were identified in the provided sources.
User avatar
Narrative Update • Jun 11

2352: Refined Assumptions And Lower Multiple Will Shape Future Upside Potential

Analysts have trimmed their price target on Qisda to NT$32.60 from about NT$36.73, reflecting updated assumptions that combine a slightly higher discount rate and revised expectations for revenue growth, profit margin, and future P/E. What's in the News No recent news items or key developments were provided for Qisda, so there are currently no specific events to highlight from the supplied sources.
User avatar
Narrative Update • Apr 02

2352: Steady Fair Value And Refined Assumptions Will Support Future Upside

Analysts have kept Qisda's fair value view broadly unchanged, with only very small tweaks to inputs like the discount rate and future P/E. These adjustments feed into a steady NT$36.73 price target that signals continued confidence in their existing valuation framework.
User avatar
Narrative Update • Mar 19

2352: Higher Profitability Assumptions And Steady Fair Value Will Support Future Upside

Analysts kept their NT$36.73 price target for Qisda unchanged, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E that effectively offset one another in their updated model. Valuation Changes Fair Value: NT$36.73 is unchanged in the updated model, indicating no revision to the overall equity value per share.
User avatar
Narrative Update • Mar 04

2352: Stable Assumptions And Slightly Higher P E Will Support A Higher Share Price

Analysts have made a small upward adjustment to their Qisda price target to reflect updated assumptions around the discount rate and future P/E. They have kept their fair value estimate broadly unchanged at about NT$36.73 per share.
User avatar
Narrative Update • Feb 18

2352: Stable Assumptions And Lower Discount Rate Will Support A Higher Share Price

Analysts have modestly adjusted their price target on Qisda to NT$36.73, reflecting fine tuning of assumptions such as a slightly lower discount rate, stable revenue growth and profit margin expectations, and a marginally revised future P/E multiple. Valuation Changes Fair Value: NT$36.73 is unchanged, indicating the updated inputs leave the core valuation estimate essentially the same.
User avatar
New Narrative • Feb 06

AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround

Catalysts About Qisda Qisda is a diversified electronics and solutions group with businesses spanning information technology hardware, medical equipment and services, smart business solutions and networking and communications. What are the underlying business or industry changes driving this perspective?
User avatar
Narrative Update • Feb 03

2352: Steady Assumptions And Higher Required Return Will Support A Higher Share Price

Analysts have kept their price target for Qisda steady at US$36.73. Modest tweaks to inputs such as the discount rate and assumed future P/E suggest only fine tuning rather than a shift in their underlying outlook.
User avatar
Narrative Update • Jan 19

2352: Stable Long Term Assumptions Will Support A Higher Future Share Price

Analysts have kept their Qisda fair value estimate steady at about $36.73 per share, with only very small model updates to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. Valuation Changes Fair Value: The intrinsic value estimate is unchanged at about NT$36.73 per share.
User avatar
Narrative Update • Jan 05

2352: Stable Assumptions And Earnings Outlook Will Support Stronger Share Price

Analysts have kept their price target for Qisda broadly in line with prior estimates. The changes reflect only very small model tweaks around discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major change in their view of the stock.
User avatar
Narrative Update • Dec 14

2352: Stable Earnings Outlook Should Support Stronger Future Share Price Performance

Analysts have raised their price target on Qisda modestly to reflect slightly lower discount rates and a marginally improved long term earnings outlook, while keeping fair value estimates effectively unchanged at around $36.73 per share. Valuation Changes Fair Value Estimate: Unchanged at approximately NT$36.73 per share, indicating no material revision in the intrinsic value assessment.
User avatar
Narrative Update • Nov 29

2352: Lower Profit Margins Will Give Way To Future Share Price Upside

Analysts have slightly revised their price target for Qisda downward from $37.80 to $36.73. This change is attributed to moderate adjustments to profit margin expectations and future earnings estimates.
User avatar
Narrative Update • Nov 15

2352: Earnings Strength and Higher Margins Will Support Upcoming Share Upside

Narrative Update: Qisda Analyst Price Target Revised Analysts have raised their price target for Qisda, increasing it from $37.80 to $37.80. This revision is based on slightly higher expected revenue growth and profit margins, along with a modest uptick in the discount rate and projected future price-to-earnings ratio.
User avatar
Narrative Update • Nov 01

2352: Investments In AIoT And Medical Services Will Boost Future Profitability

Qisda Analyst Price Target Updated Analysts have made a minor adjustment to Qisda’s price target, keeping it steady at $37.80. Recent analysis indicates only incremental changes to underlying valuation metrics.
User avatar
Narrative Update • Oct 17

Investments In AIoT And Medical Services Will Boost Future Profitability

Analysts have maintained their price target for Qisda at $37.80, citing stable financial indicators and minimal changes to key valuation metrics as supporting rationale for holding their previous outlook. Valuation Changes Fair Value: Remained unchanged at NT$37.80.
User avatar
Narrative Update • Oct 03

Investments In AIoT And Medical Services Will Boost Future Profitability

Analysts have raised their price target for Qisda from $31 to approximately $37.80, citing an adjusted fair value estimate. Other core financial projections remain consistent.
User avatar
Narrative Update • Sep 17

Investments In AIoT And Medical Services Will Boost Future Profitability

The notable downward revision in Qisda’s consensus analyst price target is primarily driven by a significant decline in net profit margin and a slight decrease in future P/E, lowering fair value from NT$35.75 to NT$31.00. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly fallen from NT$35.75 to NT$31.00.
User avatar
Narrative Update • Sep 02

Investments In AIoT And Medical Services Will Boost Future Profitability

Qisda’s higher consensus price target reflects a sharp increase in its expected future P/E ratio, signaling improved earnings growth prospects or investor confidence, raising fair value from NT$28.50 to NT$35.75. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly risen from NT$28.50 to NT$35.75.
User avatar
New Narrative • Feb 21

Investments In AIoT And Medical Services Will Boost Future Profitability

Qisda’s focus on AIoT and AI technologies may increase revenue streams and improve gross margins through innovation in smart automation solutions.
Analysis Article • Mar 12

Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture

The market wasn't impressed with the soft earnings from Qisda Corporation ( TWSE:2352 ) recently. We did some further...
Analysis Article • Mar 09

Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

Qisda Corporation ( TWSE:2352 ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...
Analysis Article • Feb 29

Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Shareholder Returns

2352TW TechTW Market
7D-1.0%-6.4%-3.1%
1Y-25.5%64.2%78.6%

Return vs Industry: 2352 underperformed the TW Tech industry which returned 64.2% over the past year.

Return vs Market: 2352 underperformed the TW Market which returned 78.6% over the past year.

Price Volatility

Is 2352's price volatile compared to industry and market?
2352 volatility
2352 Average Weekly Movement6.6%
Tech Industry Average Movement6.6%
Market Average Movement5.8%
10% most volatile stocks in TW Market11.2%
10% least volatile stocks in TW Market2.4%

Stable Share Price: 2352 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 2352's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984n/aPeter Chenwww.qisda.com

Qisda Corporation, together with its subsidiaries, manufactures, sells, and services monitors, opto-mechatronics products, and optoelectronics film in Taiwan, the Americas, Mainland China, Japan, and internationally. It operates through five segments: Design and Manufacturing Services (DMS), Brand Marketing, Materials Science, Medical Services, and Network Communication Department. The company engages in design, research, manufacturing, and sale of electronic, brand name, broadband, wireless network, and computer network system equipment products; and operates hospital profession, as well as provides medical services, hemodialysis, imaging consumables, and equipment.

Qisda Corporation Fundamentals Summary

How do Qisda's earnings and revenue compare to its market cap?
2352 fundamental statistics
Market capNT$45.44b
Earnings (TTM)NT$1.21b
Revenue (TTM)NT$208.97b
36.9x
P/E Ratio
0.2x
P/S Ratio

Is 2352 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2352 income statement (TTM)
RevenueNT$208.97b
Cost of RevenueNT$173.49b
Gross ProfitNT$35.47b
Other ExpensesNT$34.26b
EarningsNT$1.21b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.77
Gross Margin16.98%
Net Profit Margin0.58%
Debt/Equity Ratio129.2%

How did 2352 perform over the long term?

See historical performance and comparison

Dividends

3.5%
Current Dividend Yield
132%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/15 07:37
End of Day Share Price 2026/09/15 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Qisda Corporation is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Changrong ChenCapital Securities Corporation
Nicholas TeoCLSA
Joey ChengGoldman Sachs

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide